BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
3081 – 3085 of 3085
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
The HIF-2alpha-Driven Pseudo-Hypoxic Phenotype in Tumor Aggressiveness, Differentiation, and Vascularization.
Pietras, Alexander LU ; Mohlin, Sofie LU
and Påhlman, Sven
LU
(2010)
In Current Topics in Microbiology and Immunology
345.
p.1-20
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Early Metabolic Flare in Squamous Cell Carcinoma after Chemotherapy is a Marker of Treatment Sensitivity In Vitro
- Contribution to journal › Article
-
Mark
Modeling Prognostic Markers in Breast Cancer — Are We Using Them the Optimal Way?
Strand, C ; Falck, A-K ; Jirström, K LU
; Malmström, P
LU
; Rydén, L
LU
; Bendahl, P-O
LU
and Fernö, M.
LU
(2010)
In Cancer Research
70(24 Supplement).
- Contribution to journal › Published meeting abstract
-
Mark
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer : Case-control study
Vickers, Andrew J. ; Cronin, Angel M. ; Björk, Thomas LU ; Manjer, Jonas LU ; Nilsson, Peter M. LU ; Dahlin, Anders LU ; Bjartell, Anders LU ; Scardino, Peter T. ; Ulmert, David LU and Lilja, Hans LU
(2010)
In BMJ (Online)
341(7773).
- Contribution to journal › Article
-
Mark
Prediction of outcome after diagnosis of metachronous contralateral breast cancer
Alkner, Sara LU ; Bendahl, Pär-Ola LU ; Fernö, Mårten LU ; Manjer, Jonas LU and Ryden, Lisa LU
(2010)
San Antonio Breast Cancer Symposium 2010
In Cancer Research
70(Issue 24 suppl).
- Contribution to journal › Published meeting abstract